av/pacira-pharmaceuticals--big.svg

NASDAQ:PCRX

Pacira BioSciences, Inc.

  • Stock

USD

Last Close

29.86

10/05 20:00

Market Cap

1.49B

Beta: 0.76

Volume Today

5.58M

Avg: 596.19K

PE Ratio

207.02

PFCF: 11.04

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
13.82M
-
22.41M
62.19%
45.45M
102.83%
46.46M
2.22%
36.34M
21.78%
44.99M
23.79%
53.43M
18.77%
61.47M
15.05%
81.60M
32.74%
97.31M
19.25%
average payables
2.82M
-
4.91M
74.30%
7.75M
57.70%
8.13M
4.86%
11.08M
36.42%
14.51M
30.93%
13.58M
6.40%
11.62M
14.49%
10.49M
9.71%
12.88M
22.83%
average receivables
9.47M
-
18.48M
95.10%
24.11M
30.48%
27.90M
15.70%
30.80M
10.40%
34.83M
13.09%
42.77M
22.79%
50.29M
17.59%
74.68M
48.51%
97.36M
30.36%
book value per share
1.24
-
4.85
290.02%
5.98
23.27%
5.88
1.61%
7.02
19.39%
7.85
11.83%
8.55
8.89%
14.52
69.85%
16.50
13.63%
17.03
3.17%
capex per share
-0.39
-
-0.62
60.83%
-1.13
82.14%
-0.66
41.25%
-0.48
27.06%
-0.35
26.70%
-0.24
31.02%
-0.89
262.00%
-1.04
16.97%
-0.66
36.24%
capex to depreciation
-2.23
-
-2.18
2.02%
-3.60
64.88%
-1.91
46.82%
-1.39
27.18%
-1.10
20.84%
-0.52
52.93%
-1.90
265.89%
-1.61
15.39%
-0.33
79.54%
capex to operating cash flow
0.30
-
-0.86
390.30%
-1.42
65.61%
-0.74
48.11%
-1.08
46.66%
-0.30
72.58%
-0.14
51.49%
-0.49
240.64%
-0.36
25.65%
-0.21
43.25%
capex to revenue
-0.15
-
-0.11
25.95%
-0.17
49.68%
-0.09
46.06%
-0.07
24.82%
-0.04
35.98%
-0.02
43.93%
-0.09
272.27%
-0.08
5.71%
-0.05
46.75%
cash per share
2.17
-
7.86
261.28%
7.14
9.10%
4.64
35.09%
7.82
68.74%
9.37
19.83%
7.03
24.97%
12.23
73.83%
14.83
21.31%
6.34
57.24%
days of inventory on hand
103.67
-
137.93
33.04%
313.21
127.09%
103.69
66.90%
171.93
65.81%
204.13
18.73%
199.40
2.32%
201.12
0.87%
256.47
27.52%
175.94
31.40%
days payables outstanding
20.45
-
31.85
55.75%
44.40
39.40%
24.90
43.92%
60.86
144.41%
60.39
0.77%
43.78
27.50%
32.45
25.88%
27.44
15.45%
27.87
1.60%
days sales outstanding
62.25
-
41.30
33.65%
37.90
8.23%
39.54
4.32%
40.31
1.96%
41.12
2.01%
41.21
0.20%
46.01
11.66%
64.92
41.10%
53.86
17.04%
debt to assets
1.17
-
0.63
45.74%
0.54
14.02%
0.28
48.92%
0.44
58.41%
0.42
4.09%
0.42
0.34%
0.42
0.26%
0.54
28.11%
0.45
16.52%
debt to equity
4.80
-
1.20
74.89%
0.97
19.48%
0.50
48.81%
0.99
99.23%
0.91
8.45%
0.99
9.47%
0.87
11.93%
1.55
76.99%
0.99
36.27%
dividend yield
0.00
-
0.00
72.38%
0.00
58.39%
earnings yield
-0.03
-
-0.00
86.92%
0.00
115.09%
-0.03
4,870.13%
-0.02
25.68%
-0.00
98.86%
-0.01
2,088.93%
0.06
1,072.89%
0.02
72.34%
0.01
42.58%
0.02
164.29%
enterprise value
1.99B
-
3.07B
54.18%
2.75B
10.46%
1.28B
53.67%
2.04B
59.90%
1.92B
5.94%
2.15B
12.29%
2.99B
39.01%
3.21B
7.08%
2.42B
24.63%
enterprise value over ebitda
-42.13
-
-622.13
1,376.63%
276.17
144.39%
-41.44
115.00%
-128.89
211.05%
83.09
164.47%
49.17
40.83%
44.79
8.91%
22.17
50.49%
19.90
10.26%
ev to operating cash flow
-46.14
-
120.72
361.62%
94.94
21.35%
38.13
59.84%
114.68
200.76%
39.26
65.77%
30.55
22.18%
38.87
27.26%
25.51
34.39%
16.64
34.77%
ev to sales
23.31
-
15.55
33.27%
11.06
28.92%
4.62
58.26%
7.12
54.17%
5.69
20.06%
5.12
10.04%
7.12
39.08%
5.92
16.79%
3.62
38.79%
free cash flow per share
-1.69
-
0.10
106.01%
-0.34
431.21%
0.23
169.91%
-0.04
115.84%
0.84
2,357.13%
1.45
73.14%
0.92
36.77%
1.80
96.22%
2.53
40.28%
2.76
8.87%
free cash flow yield
-0.03
-
0.00
103.90%
-0.00
482.40%
0.01
266.20%
-0.00
111.21%
0.02
2,495.11%
0.03
64.43%
0.02
52.13%
0.03
95.15%
0.07
118.61%
0.08
24.59%
graham net net
-1.14
-
4.36
483.47%
3.83
12.10%
1.03
73.21%
0.17
83.08%
1.66
859.35%
-2.88
272.72%
-1.43
50.24%
-12.81
795.35%
-10.89
14.99%
graham number
7.34
-
6.51
11.29%
2.61
59.86%
11.61
344.32%
13.00
11.98%
1.43
89.03%
7.14
400.99%
33.38
367.21%
18.77
43.78%
11.57
38.34%
income quality
0.68
-
-1.86
374.60%
15.62
941.35%
-0.88
105.64%
-0.42
52.65%
-103.76
24,759.32%
-6.40
93.83%
0.53
108.27%
2.99
465.73%
9.13
204.93%
intangibles to total assets
0.07
-
0.07
9.58%
0.08
7.23%
0.12
50.24%
0.09
26.42%
0.09
2.45%
0.25
172.66%
0.15
37.31%
0.37
140.91%
0.42
12.96%
0
100%
interest coverage
-7.35
-
-0.62
91.51%
1.22
296.16%
-4.54
470.55%
-1.38
69.53%
0.73
152.48%
1.61
122.44%
1.81
11.94%
4.13
128.63%
1.50
63.63%
-4.32
387.56%
interest debt per share
6.18
-
6.08
1.74%
6.01
1.10%
3.11
48.25%
7.40
137.94%
7.65
3.36%
9.05
18.29%
13.28
46.83%
26.22
97.40%
17.65
32.69%
inventory turnover
3.52
-
2.65
24.84%
1.17
55.96%
3.52
202.07%
2.12
39.69%
1.79
15.78%
1.83
2.37%
1.81
0.86%
1.42
21.58%
2.07
45.77%
invested capital
4.80
-
1.20
74.89%
0.97
19.48%
0.50
48.81%
0.99
99.23%
0.91
8.45%
0.99
9.47%
0.87
11.93%
1.55
76.99%
0.99
36.27%
market cap
1.91B
-
3.13B
64.06%
2.81B
10.34%
1.20B
57.14%
1.82B
51.09%
1.76B
3.15%
1.88B
6.85%
2.55B
35.78%
2.66B
4.30%
1.76B
34.01%
1.75B
0.22%
net current asset value
-21.82M
-
59.33M
371.91%
81.35M
37.12%
70.60M
13.22%
42.22M
40.19%
109.84M
160.15%
-67.56M
161.51%
-3.20M
95.26%
-478.90M
14,856.18%
-407.86M
14.83%
net debt to ebitda
-1.83
-
11.14
710.07%
-5.32
147.75%
-2.36
55.56%
-14.05
494.26%
6.86
148.82%
6.25
8.95%
6.60
5.62%
3.76
43.07%
5.43
44.48%
net income per share
-1.93
-
-0.39
79.83%
0.05
113.07%
-1.02
2,106.45%
-1.07
5.04%
-0.01
98.92%
-0.27
2,204.94%
3.41
1,385.17%
0.95
72.19%
0.35
63.15%
0.81
130.95%
operating cash flow per share
-1.30
-
0.72
155.40%
0.79
9.98%
0.90
13.21%
0.45
50.27%
1.19
167.36%
1.70
42.21%
1.81
6.27%
2.84
57.33%
3.19
12.36%
2.76
13.67%
payables turnover
17.85
-
11.46
35.79%
8.22
28.26%
14.66
78.33%
6.00
59.08%
6.04
0.78%
8.34
37.94%
11.25
34.91%
13.30
18.27%
13.09
1.57%
receivables turnover
5.86
-
8.84
50.72%
9.63
8.97%
9.23
4.14%
9.05
1.93%
8.88
1.97%
8.86
0.20%
7.93
10.44%
5.62
29.13%
6.78
20.53%
research and ddevelopement to revenue
0.25
-
0.09
62.40%
0.12
21.48%
0.17
43.58%
0.20
20.93%
0.17
17.39%
0.17
3.74%
0.14
17.57%
0.10
27.36%
0.13
23.98%
0.11
11.16%
return on tangible assets
-0.40
-
-0.05
88.74%
0.01
111.39%
-0.11
2,227.31%
-0.07
32.47%
-0.00
98.99%
-0.02
2,239.53%
0.13
868.19%
0.03
76.18%
0.02
49.36%
revenue per share
2.58
-
5.60
117.20%
6.81
21.69%
7.42
8.92%
7.20
2.98%
8.24
14.49%
10.14
23.02%
9.86
2.76%
12.23
24.06%
14.65
19.73%
12.99
11.35%
roe
-1.55
-
-0.08
94.83%
0.01
110.60%
-0.17
2,139.21%
-0.15
12.02%
-0.00
99.04%
-0.03
2,016.67%
0.23
856.65%
0.06
75.53%
0.02
64.28%
roic
-0.22
-
-0.01
93.74%
0.02
238.78%
-0.10
609.33%
-0.05
54.08%
0.03
164.03%
0.05
80.10%
0.27
422.11%
0.05
81.43%
0.04
11.50%
sales general and administrative to revenue
0.24
-
0.21
13.99%
0.25
16.85%
0.23
6.84%
0.23
1.43%
0.21
10.60%
0.17
18.80%
0.18
5.27%
0.16
8.28%
0.16
0.70%
shareholders equity per share
1.24
-
4.85
290.02%
5.98
23.27%
5.88
1.61%
7.02
19.39%
7.85
11.83%
8.55
8.89%
14.52
69.85%
16.50
13.63%
17.03
3.17%
stock based compensation to revenue
0.13
-
0.13
6.69%
0.13
6.72%
0.11
15.63%
0.11
2.49%
0.09
14.68%
0.08
15.03%
0.09
18.69%
0.08
17.76%
0.07
7.55%
0.07
1.61%
tangible asset value
29.76M
-
146.98M
393.82%
187.43M
27.52%
172.24M
8.11%
224.29M
30.22%
259.19M
15.56%
151.01M
41.74%
423.62M
180.52%
-38.73M
109.14%
71.22M
283.87%
tangible book value per share
0.90
-
4.16
364.21%
5.13
23.19%
4.63
9.82%
5.63
21.81%
6.34
12.44%
3.64
42.58%
9.93
172.91%
-0.88
108.82%
1.56
278.78%
working capital
-15.19M
-
74.25M
588.72%
100.91M
35.91%
198.25M
96.47%
334.89M
68.92%
417.31M
24.61%
300.88M
27.90%
398.30M
32.37%
344.93M
13.40%
350.56M
1.63%

All numbers in USD (except ratios and percentages)